Financial Statements — RADX
Balance Sheet
(in millions USD)| Metric | FY
2025 |
|---|
| Cash & Equivalents | 29.12 |
| Total Current Assets | 39.85 |
| Total Non-current Assets | 46.63 |
| Total Assets | 86.48 |
| Total Current Liabilities | 14.93 |
| Total Non-current Liabilities | 28.68 |
| Total Liabilities | 43.61 |
| Total Stockholder Equity | 42.87 |
Income Statement
(in millions USD) (except per-share rows)| Metric | FY
2025 |
|---|
| Total Revenue | 3.63 |
| Cost of Revenue* | 3.59 |
| Gross Profit | 0.04 |
| Research & Development | 27.52 |
| Selling, General & Admin | 14.64 |
| Total Operating Expenses* | 38.21 |
| Operating Income | (38.17) |
| Pretax Income | (38.24) |
| Tax Provision | 0.10 |
| Net Income | (38.34) |
| Basic EPS | (1.76) |
| Diluted EPS | (1.76) |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | FY
2025 |
|---|
| Operating Cash Flow | (36.65) |
| Investing Cash Flow | 1.77 |
| Financing Cash Flow | 45.43 |
